Will Google help diagnose skin diseases?
Google has recently introduced an online tool with the help of artificial intelligence that can make an early diagnosis of skin diseases, but experts are expressing their concerns.
According to the international website, experts have expressed concern over the online tool developed by Google, the world’s largest search engine and internet technology company, for the initial diagnosis of skin diseases, calling it unrealistic.
Google announced in May last year that it had developed an online tool developed with the help of artificial intelligence, and now experts have expressed concern over the completion of the tool.
According to Google, it has developed a system of artificial intelligence that works like a CT scan after three years of hard work and after reviewing images of thousands of people suffering from skin diseases.
Google announced in its blog in May 2021 that the Dermatology Assistant tool works just like the screening technology used to diagnose breast cancer.
According to Google, 65,000 different colors, problems and diseases were shown to the artificial intelligence system during the development of the tool.
Google had said that the web application-style tool would allow any user to take pictures with their mobile phone camera to find out the possible nature of the problem.
However, dermatologists on Google’s tool have expressed concern that artificial intelligence is not able to fully recognize the colors of human skin and that the tool will only be able to detect white, brown or black, while white There are also different levels of.
Experts have expressed concern that those who get information about the disease or problem with the artificial intelligence tool will be more anxious and hesitant.
Experts say that the tool will not be able to accurately identify skin, hair and nail problems and people will be upset as a result of possible misdiagnosis.
Note that although Google has developed the tool, it has not yet been made available to the public, it will only be made available for use after approval by governments and healthcare agencies.